Nov 09, 2021 / 09:30PM GMT
Operator
Good day, and welcome to the Inovio Third Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please note, this event is bring recorded. I would now like to turn the conference over to Ben Matone, Senior Director of Investor Relations. Please go ahead.
Ben Matone - Inovio Pharmaceuticals, Inc. - Director of IR
Thank you, operator. Good afternoon, and thank you for joining the Inovio Third Quarter 2021 Earnings Conference Call. Joining me on today's call are Dr. Joseph Kim, President and CEO; Mr. Peter Kies, Chief Financial Officer; Dr. Jacqui Shea, Chief Operating Officer; Dr. Laurent Humeau, Chief Scientific Officer; Dr. Jeffrey Skolnik, Senior Vice President of Clinical Development; Dr. Anza Mammen, Senior Vice President of Clinical Development; and Dr. Kate Broderick, Senior Vice President of Research and Development.
For today's call, we will review our corporate and financial information for the third quarter ending September 30, 2021. We will also discuss our COVID-19 vaccine development efforts that address both current and
Q3 2021 Inovio Pharmaceuticals Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot